Showing results (21-30 of 3,109) with videos related to

Sort By:
Pageof 311
Blood|December 1, 1984
Plasma protein S deficiency in familial thrombotic diseaseH P Schwarz, M Fischer, P Hopmeier, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1993
[Detection of lupus anticoagulants in the routine blood coagulation laboratory exemplified by 36 patients with systemic lupus erythematosus]W M Halbmayer, A Haushofer, W Schratzberger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimenA Haushofer, W M Halbmayer, M Dittel, et al.
Coronary Artery Disease|May 1, 1994
Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgeryW M Halbmayer, A Haushofer, J Radek, et al.
Coronary Artery Disease|May 1, 1995
Platelet size, fibrinogen and lipoprotein(a) in coronary heart diseaseW M Halbmayer, A Haushofer, J Radek, et al.
Hamostaseologie|August 18, 2004
[Monitoring of tienopyridines or glycoprotein IIb/IIIa-receptor antagonists: simple platelet function tests]W-M Halbmayer
Thrombosis Research|September 28, 1999
Rational, high quality laboratory monitoring before, during, and after infusion of prothrombin complex concentratesW M Halbmayer
Thrombosis and Haemostasis|January 1, 1994
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donorsW M Halbmayer, A Haushofer, R Schön, et al.
Zeitschrift Fur Kardiologie|January 1, 1995
[Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]M Dittel, A Haushofer, R Spiel, et al.
Wiener Klinische Wochenschrift|July 13, 1990
[A simple test for the monitoring of plasma anti-XA activity of patients following subcutaneous administration of enoxaparin]W M Halbmayer, C Feichtinger, T Schwarz, et al.
Pageof 311